In Western Europe, Muslims' cultural attitudes take center stage in debates in media and politics. In these debates, the claim that Muslims' religious interpretations cause them to be intolerant of homosexual people is often repeated. While previous public opinion studies have time and again shown that Muslims are indeed on average more homonegative than other people, the present study theoretically explores and empirically tests whether those differences are Islamic religiosity. This assumption is often made but has yet to be empirically addressed. Using unique data on young Muslim adults in the Netherlands and more direct measurements of religious interpretations on homosexuality, we find that Islamic religiosity as such hardly fuels intolerance of homosexual people. In fact, our results show that even believing that Islam forbids homosexuality does not necessarily fuel Muslims' intolerance of homosexual people. Rather, what is pivotal, is whether such beliefs are coupled with a willingness to judge, rather than leaving judgment to Allah. We conclude that only among young adult Dutch Muslims who believe it is up to them to judge homosexuality, do homonegative interpretations of Islam feed into intolerance of homosexual people.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/00918369.2023.2267723 | DOI Listing |
JMIR Hum Factors
January 2025
Hackensack Meridian School of Medicine, 123 Metro Blvd, Nutley, NJ, 07110, United States, 1 7248419463.
Background: Transgender and nonbinary (TGNB) individuals are increasingly intentionally becoming pregnant to raise children, and hospital websites should reflect these trends. For prospective TGNB parents, a hospital website is the only way they can assess their safety from discrimination while receiving perinatal care. Cisnormativity enforced by communication gaps between medical institutions and TGNB patients can and has caused delays in receiving urgent care during their pregnancy.
View Article and Find Full Text PDFBrain Behav
January 2025
Department of Medical Genetics, Faculty of Medicine, Dokuz Eylül University, Izmir, Türkiye.
Purpose: Genetic studies on the transgender and gender diverse (TGD) community have started to appear in the literature. However, there are limited studies on how genetic data will impact attitudes and perspectives toward TGD individuals. In this study, we investigated the impact of genetic alterations on physicians' attitudes toward TGD individuals and on physicians' decisions concerning gender confirmation surgery (GCS).
View Article and Find Full Text PDFBMJ Open
January 2025
Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Introduction: Cardiovascular diseases (CVDs) present differently in women and men, influenced by host-microbiome interactions. The roles of sex hormones in CVD outcomes and gut microbiome in modifying these effects are poorly understood. The XCVD study examines gut microbiome mediation of sex hormone effects on CVD risk markers by observing transgender participants undergoing gender-affirming hormone therapy (GAHT), with findings expected to extrapolate to cisgender populations.
View Article and Find Full Text PDFPLoS One
January 2025
Indiana University Interprofessional Practice and Education Center, Indianapolis, IN, United States of America.
Background: Disproportionate access to healthcare services among the Lesbian, Gay, Bisexual, Transgender, Queer or Questioning and others (LGBTQ+) population can be partially attributed to the lack of cultural competence among healthcare providers. The aim of this study was to evaluate the impact of an interprofessional model in improving cultural competence and clinical preparedness among dental and pharmacy students for providing LGBTQ+ specific care.
Methodology: This study is a retrospective observational study which used a novel interprofessional model of three different LGBTQ+ focused educational interventions within a group of dental and pharmacy students.
PLoS One
January 2025
Maple Health Group, LLC, New York, United States of America.
The US faces substantial demographic and geographic disparities in both HIV burden and access to pre-exposure prophylaxis (PrEP), an effective strategy to prevent HIV acquisition. Long-acting cabotegravir (CAB) is a novel, injectable PrEP option which demonstrated superior reduction in risk of HIV acquisition compared to daily-oral PrEP in the HPTN083 trial. We modelled the impact of increased PrEP initiations and the introduction of long-acting CAB on HIV incidence among men who have sex with men (MSM) in Atlanta, Georgia, a population with a high burden of HIV.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!